Stem Sel Srl: Funding, Investors & Team (Sep 2026)
Stem Sel Srl is a spin off founded in 2013 by entrepreneurs belonging from the University of Bologna, and participated from AlmaCube Srl and investors. The business of Stem Sel is based on the development, engineering, production and commercialization of an instrumentation (and related consumables), called Celector (R). The disruptive trait of Celector (R) innovation lies on its proprietary technology for tag-less separation and selection of cells, particularly human stem cells from complex, adult "discarded" tissues (e.g. placenta, umbilical cord, lipoaspirate, dental pulp). These cells are increasingly used for cell therapy applications in regenerative medicine. Celector(R) separates, profile, characterize, counts, isolate and collect best cells without manipulation. Celector(R) is relies on a robust management of IP based on a clusters of different national and international patents on its methods, technologies, and devices for the cell fractionation process.
Stem Sel Srl has raised $100k across 1 funding round on record, the most recent an undisclosed round of $100k announced in Dec 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Stem Sel Srl Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Stem Sel Srl Funding Rounds
Stem Sel Srl Founders and Leadership Team
No contact details are on record for this team yet.
Stem Sel Srl Funding Compared to Other Biotechnology Startups
Stem Sel Srl's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stem Sel Srl in Biotechnology and Bologna
Companies Similar to Stem Sel Srl
NOUS is a biotech startup working on developing a new era of ingredients for Food&Beverage and Nutraceutical…
Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates…
Oraigo is a leading company in the development of innovative road safety technology, utilizing brain-computer…
FTnet is a digital platform in the pharmaceutical industry that employs advanced technology to connect…
Genoa Instruments is a cutting-edge startup focused on revolutionizing biomedical and health research using…
Resalis Therapeutics is focusing on addressing metabolic diseases by targeting a key regulator linked to…
CoRe is an Italian start-up, aimed at the study of new product and process solutions in the field of…
Established in 1999, PHSE is a leading provider of time-sensitive and temperature-controlled transport…
MOGU, an Italian-based European company, is dedicated to developing a variety of mycelium-based technologies…
A biotech business called DIAMANTE (Nano-Technologies for Autoimmune Disease) is dedicated to using plants to…
Relicta developed a water-soluble, transparent and biodegradable plastic for packaging made from fish…
Stem Sel Srl Funding FAQs
What does Stem Sel Srl do?
Stem Sel Srl is a spin off founded in 2013 by entrepreneurs belonging from the University of Bologna, and participated from AlmaCube Srl and investors. The business of Stem Sel is based on the development, engineering, production and commercialization of an instrumentation (and related consumables), called Celector (R). The disruptive trait of Celector (R) innovation lies on its proprietary technology for tag-less separation and selection of cells, particularly human stem cells from complex, adult "discarded" tissues (e.g. placenta, umbilical cord, lipoaspirate, dental pulp). These cells are increasingly used for cell therapy applications in regenerative medicine. Celector(R) separates, profile, characterize, counts, isolate and collect best cells without manipulation. Celector(R) is relies on a robust management of IP based on a clusters of different national and international patents on its methods, technologies, and devices for the cell fractionation process.
How much funding has Stem Sel Srl raised?
Stem Sel Srl has raised $100k across 1 round on record. The most recent is an undisclosed round of $100k announced in Dec 2021.
When did Stem Sel Srl last raise funding?
Stem Sel Srl's most recent funding round on record is an undisclosed round of $100k, announced in Dec 2021.
Who is the CEO of Stem Sel Srl?
Pierluigi Reschiglian is listed as CEO at Stem Sel Srl.
Where is Stem Sel Srl headquartered?
Stem Sel Srl is based in Bologna, Emilia-Romagna, Italy.
How many employees does Stem Sel Srl have?
Stem Sel Srl is in the 1-10 employee band.
How does Stem Sel Srl's funding compare to other Biotechnology startups?
Stem Sel Srl's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Stem Sel Srl Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stem Sel Srl is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.